HomeCompareBCCOY vs MAIN

BCCOY vs MAIN: Dividend Comparison 2026

BCCOY yields 533.33% · MAIN yields 7.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCCOY wins by $101452.28M in total portfolio value
10 years
BCCOY
BCCOY
● Live price
533.33%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$101500.22M
Annual income
$74,150,491,507.64
Full BCCOY calculator →
MAIN
Main Street Capital Corporation
● Live price
7.09%
Share price
$51.65
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.95M
Annual income
$40,208,699.11
Full MAIN calculator →

Portfolio growth — BCCOY vs MAIN

📍 BCCOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCCOYMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCCOY + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCCOY pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCCOY
Annual income on $10K today (after 15% tax)
$45,333.33/yr
After 10yr DRIP, annual income (after tax)
$63,027,917,781.49/yr
MAIN
Annual income on $10K today (after 15% tax)
$602.32/yr
After 10yr DRIP, annual income (after tax)
$34,177,394.24/yr
At 15% tax rate, BCCOY beats the other by $62,993,740,387.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCCOY + MAIN for your $10,000?

BCCOY: 50%MAIN: 50%
100% MAIN50/50100% BCCOY
Portfolio after 10yr
$50774.09M
Annual income
$37,095,350,103.38/yr
Blended yield
73.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MAIN right now

BCCOY
No analyst data
Altman Z
-2.5
Piotroski
4/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+26.3% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCCOY buys
0
MAIN buys
0
No recent congressional trades found for BCCOY or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCCOYMAIN
Forward yield533.33%7.09%
Annual dividend / share$2.00$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%72.7%
Portfolio after 10y$101500.22M$47.95M
Annual income after 10y$74,150,491,507.64$40,208,699.11
Total dividends collected$99158.23M$46.82M
Payment frequencyquarterlymonthly
SectorStockBDC

Year-by-year: BCCOY vs MAIN ($10,000, DRIP)

YearBCCOY PortfolioBCCOY Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$64,033$53,333.33$12,464$1,223.78+$51.6KBCCOY
2$387,685$319,169.26$16,353$2,343.58+$371.3KBCCOY
3$2,220,791$1,805,968.17$23,105$4,724.42+$2.20MBCCOY
4$12,044,657$9,668,410.74$36,226$10,256.23+$12.01MBCCOY
5$61,894,777$49,006,993.47$65,426$24,707.64+$61.83MBCCOY
6$301,588,053$235,360,641.70$142,101$68,562.02+$301.45MBCCOY
7$1,394,490,436$1,071,791,219.76$388,521$228,799.95+$1394.10MBCCOY
8$6,123,670,416$4,631,565,648.90$1,397,868$961,169.80+$6122.27MBCCOY
9$25,560,497,666$19,008,170,321.16$6,884,663$5,313,459.69+$25553.61MBCCOY
10$101,500,224,010$74,150,491,507.64$47,947,060$40,208,699.11+$101452.28MBCCOY

BCCOY vs MAIN: Complete Analysis 2026

BCCOYStock

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.

Full BCCOY Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this BCCOY vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCCOY vs SCHDBCCOY vs JEPIBCCOY vs OBCCOY vs KOBCCOY vs ARCCBCCOY vs HTGCBCCOY vs GBDCBCCOY vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.